LUIS E. MENDEZ, MD

Plain English
This study looked at the different types of posttraumatic stress symptoms (PTSS) in 296 young people involved in the justice system. Researchers found five distinct patterns of symptoms, with some youth showing classic symptoms, others having more severe dissociative symptoms, and those with higher trauma experiences typically showing more severe symptoms. This research is important because it helps identify varying needs for treatment among at-risk youth, making it easier to tailor support for them. Who this helps: This research benefits justice-involved adolescents and the professionals who work with them.

Plain English
This study examined a 67-year-old man who had recurring fevers and joint pain, along with pink, bumpy skin. Doctors found that he had a specific genetic mutation linked to a condition called VEXAS syndrome, which causes inflammation and skin issues. Identifying this rare syndrome is important because it helps doctors know how to treat patients with similar unexplained symptoms. Who this helps: Patients with VEXAS syndrome and their healthcare providers.

Plain English
This study looked at a software that uses deep learning to help doctors outline areas in CT scans for gynecological radiation treatment. Researchers analyzed CT images from 30 patients and found that the software's contours were very close to those made by specialists, especially for the bladder and rectum, with scores of 0.92 and 0.79 respectively. Using this software made the contouring process faster, reducing the time needed from 14.8 minutes to 6.9 minutes per patient, which is significant for improving efficiency in medical settings. Who this helps: This benefits doctors and radiologists by providing quicker and more accurate contouring for gynecological treatments.

Plain English
Researchers examined the effectiveness and side effects of two antifungal medications, isavuconazole and voriconazole, in patients with acute myeloid leukemia (AML) who are at risk for infections. They found that patients taking voriconazole had more severe side effects, leading to nearly 18% discontinuation due to liver issues and visual problems, while isavuconazole was often stopped due to high costs or insurance issues instead of side effects. This matters because isavuconazole is a safer option and can effectively prevent fungal infections in these vulnerable patients. Who this helps: This helps patients with acute myeloid leukemia and their doctors.

Plain English
This study looked at how a bacteria called Mycobacterium avium subspecies paratuberculosis, which causes a disease known as paratuberculosis, can be passed from pregnant goats to their unborn kids. Researchers found that 75% of the pregnant goats showed signs of the disease, and 22% of the fetuses had the bacteria present, with those from infected mothers being nearly eight times more likely to also be infected. This shows that the bacteria can be transmitted from mother to fetus in goats, which is important for developing better control strategies for this disease in livestock. Who this helps: This information benefits farmers and veterinarians working with goats.

Plain English
This study looked at two treatment options for patients with acute myeloid leukemia (AML) who have very high-risk genetic features. Researchers compared intensive chemotherapy to a combination of a hypomethylating agent and venetoclax in 358 patients. They found that both treatments had similar success rates in achieving remission (about 55% for chemotherapy and 54% for the other treatment), and the average survival for all patients with very high-risk AML was just 8 months, much shorter than those without high-risk features who survived about 31 months. Who this helps: This information benefits patients with very high-risk AML and their doctors by providing effective treatment options.

Plain English
This study looked at how experiences of physical violence and mental health issues affect whether teenagers join gangs. Researchers analyzed data from over 6,500 young people and found that those with post-traumatic stress disorder (PTSD) were more likely to join gangs after being victimized, while those with major depressive disorder (MDD) were less likely to do so. This research highlights the importance of understanding mental health when addressing youth gang involvement. Who this helps: This benefits teenagers at risk of gang involvement, mental health professionals, and community programs.

Plain English
This study looked at patients with acute myeloid leukemia (AML) who had a history of myeloproliferative neoplasms (MPNs) to see how new treatments affected their survival. It found that the average survival for patients diagnosed with post-MPN AML was about 7.1 months before new therapies and 7.6 months afterwards, showing no significant improvement. However, only 15% of these patients received stem cell transplants, which significantly improved survival to an average of 20.5 months compared to just 5.8 months for those who did not get the transplant. Who this helps: Patients with post-MPN AML and their doctors.

Plain English
This study looked at the costs and benefits of using a drug called eltrombopag alongside standard immunosuppressive therapy to treat adults with severe aplastic anemia, a serious blood disorder. The findings indicated that patients receiving both treatments gained more quality-adjusted life years (11.53 years) and had a net monetary benefit of $64,000 compared to those receiving only standard therapy. This is important because it shows that adding eltrombopag can provide better health outcomes at a reasonable cost. Who this helps: This benefits patients with severe aplastic anemia and their doctors by offering a more effective treatment option.

Plain English
This study looked at the safety and results of sending some patients with newly diagnosed acute myeloid leukemia (AML) home earlier than usual after their initial treatment. Out of 185 patients, 99 (or about 54%) were discharged while still having low white blood cell counts, specifically with less than 0.5 x 10/μL. Those who went home early had fewer hospital days (23 days instead of 28) and did not experience higher death rates within 90 days. Who this helps: This helps patients with acute myeloid leukemia who can go home sooner, allowing them to recover in a more comfortable environment.

Plain English
This study focused on creating a new tool to help match cancer patients with clinical trials more efficiently. The tool, which uses artificial intelligence to screen patient data, showed impressive results: it matched patients with a 94% accuracy rate and cut the time doctors spent reviewing patient charts by 41%. This matters because it can speed up patient enrollment in clinical trials, giving patients better access to potentially life-saving treatments. Who this helps: This helps cancer patients seeking new treatment options and researchers looking to improve trial enrollment.

Plain English
This study focused on a new treatment for multiple myeloma, a type of cancer that affects the blood. Researchers tested a drug called SAR445514, which helps special immune cells called natural killer (NK) cells target and destroy cancer cells. SAR445514 was found to be particularly effective, showing strong anti-cancer activity while causing fewer side effects compared to other treatments, especially in patients whose cancer was resistant to standard therapies. Who this helps: This helps multiple myeloma patients seeking better treatment options.

Plain English
This study looked at reasons why many leukemia clinical trials are stopped before they're finished. Out of 3,522 trials reviewed, 28.4% were ended early, with slow participant recruitment being the main reason, affecting 38.2% of those trials. The problem of early termination is growing, especially in smaller and academic-sponsored trials, which have higher cancellation rates. Who this helps: This research benefits patients and researchers by highlighting challenges in leukemia trials and guiding improvements in future studies.

Plain English
This study looked at the drug enasidenib and its effectiveness compared to standard treatments for older patients with a specific type of leukemia that has returned or doesn't respond to treatment. It found that while enasidenib offered a small benefit of 0.234 quality-adjusted life years (QALYs), it also came with a high cost of $126,800, resulting in a cost-effectiveness ratio of $540,300 per QALY. This means that enasidenib is not likely to be considered a cost-effective treatment at its current price; it would need to be significantly cheaper to be worthwhile. Who this helps: This research helps healthcare providers and policymakers in deciding on treatment options for older patients with this type of leukemia.

Plain English
This study looked at how tiny particles from the blood of pregnant women with preeclampsia affect the blood-brain barrier, a protective layer around the brain. Researchers found that these particles significantly lowered the levels of a protein called CLDN5, which is crucial for maintaining this barrier. Specifically, they saw that the particles from women with preeclampsia and those from oxygen-deprived placentas reduced CLDN5 levels, leading to potential brain damage and neurological issues in test subjects. Who this helps: This research helps doctors better understand and potentially treat complications related to preeclampsia in pregnant women.

Plain English
This study looked at how a lack of prior chemistry knowledge affects students' performance in introductory biology courses. Researchers found that students who had gaps in their chemistry education tended to perform worse on their biology exams, especially the first one. They created a new online program to help these students learn chemistry concepts better, and this support is crucial for improving their understanding and grades in biology. Who this helps: This helps students who struggle with biology due to gaps in their chemistry knowledge.

Plain English
This study looked at how bipolar disorder is connected to heart disease, finding that people with bipolar disorder face a higher risk of heart problems due to both biological and lifestyle factors. Specifically, these patients often experience more severe cardiovascular issues, which can worsen their mental health and increase healthcare costs. Addressing heart health in patients with bipolar disorder can lead to better outcomes for both their heart and mental health. Who this helps: This helps patients with bipolar disorder and their healthcare providers.

Plain English
This study looked at how radiation treatment affects patients with brainstem tumors and arteriovenous malformations (AVMs) when they undergo a specific type of therapy called stereotactic radiosurgery (SRS). Researchers analyzed data from 124 patients and found that about 9.7% experienced harmful radiation effects, with the most significant risks occurring in those treated for brainstem metastases, especially when the treatment volume was larger than 1 cubic centimeter. Understanding these risks helps doctors adjust treatment plans to minimize harmful side effects while effectively targeting the tumors. Who this helps: Patients undergoing treatment for brainstem metastases and AVMs.

Plain English
This study tested a new drug called MK-6194, which aims to boost a type of immune cell known as regulatory T cells (Tregs), in healthy volunteers. Researchers found that MK-6194 was safe, with no serious side effects reported, and it effectively increased Tregs by up to five times after about eight days, returning to normal levels within a few weeks. These results are important because they suggest MK-6194 could be a promising treatment for autoimmune diseases, where the immune system attacks the body. Who this helps: This helps patients with autoimmune disorders.

Plain English
This study looked at how RNA splicing factor mutations affect the treatment outcomes of older patients with acute myeloid leukemia (AML) and higher-risk myelodysplastic syndromes (HR-MDS) when they are treated with azacitidine, with or without an immune therapy called durvalumab. The researchers found that the response rates and survival times were similar for patients with and without these mutations; for example, the overall response rate for SF-mutant AML patients was 35.3%, compared to 33.3% for those without mutations. This is important because it indicates that the presence of these mutations does not change how patients respond to this treatment, meaning doctors can use azacitidine effectively regardless of the mutation status. Who this helps: This benefits patients with AML and HR-MDS, as well as their doctors making treatment decisions.

Plain English
This study looked at the costs and benefits of performing a stem cell transplant right away versus waiting until a patient's cancer returns in adults with intermediate-risk acute myeloid leukemia (AML). Researchers found that doing the transplant upfront is not only more effective in prolonging the time without cancer but is also more cost-effective, showing a financial benefit of about $497,100 in the U.S. and £235,600 in the U.K. for the upfront approach compared to delaying the procedure. This matters because it indicates that starting treatment with an upfront stem cell transplant can lead to better health outcomes and save money for healthcare systems. Who this helps: Patients with intermediate-risk AML will benefit the most from this approach.

Plain English
This study looked at how effective a protein called PAX5 is for diagnosing different types of acute leukemia, especially when another common marker, CD19, is weak. Researchers examined 55 cases with low CD19 expression and found that PAX5 accurately identified 100% of B-cell acute lymphoblastic leukemia (B-ALL) cases and 98% of other acute leukemias with weak CD19. This is important because using PAX5 can help doctors make better diagnoses when traditional methods fall short, particularly for patients with complex leukemia types. Who this helps: This helps doctors and patients facing ambiguous leukemia diagnoses.

Plain English
Researchers studied a treatment called luspatercept for patients who have a type of anemia related to lower-risk myelodysplastic syndromes and need blood transfusions. They found that about 51.2% of patients no longer needed transfusions after 8 weeks, and this rate was even higher (72.9%) for those with a lower need for transfusions. This is important because luspatercept offers a new option for managing anemia in these patients, potentially improving their quality of life and health outcomes. Who this helps: This helps patients suffering from anemia due to lower-risk myelodysplastic syndromes.

Plain English
Researchers studied how eye movements, tracked with artificial intelligence, can detect early signs of Alzheimer's disease in people who carry a specific genetic mutation. They tested 100 mutation carriers, including 89 who show no symptoms, and found that their eye movement patterns could accurately identify those at risk with an impressive 100% accuracy for symptomatic carriers and 96% for asymptomatic ones, which is much better than traditional cognitive tests. This is important because it offers a new, reliable way to spot Alzheimer's risk before symptoms appear, allowing for earlier intervention. Who this helps: Patients at risk for familial Alzheimer's disease and their families.

Plain English
This study looked at older patients with specific blood disorders—polycythemia vera, essential thrombocythemia, and myelofibrosis—to see if a medication called ruxolitinib increased the risk of developing new cancers. Researchers analyzed data from over 6,000 patients and found that using ruxolitinib did not raise the risk of developing any new malignancies. Specifically, nearly 470 patients developed new cancers during the study, but ruxolitinib users had a similar risk of new cancers as those who did not use the medication. Who this helps: This information benefits older patients with blood disorders and their doctors by providing reassurance about the safety of ruxolitinib.

Plain English
This study looked at how well essential oils can fight against a specific bird flu virus, H7N3. The researchers found that these oils were effective at reducing the virus's activity, with concentrations as low as 20.4 parts per million showing good results in lab tests, and even better effects when used 24 hours before exposure to the virus in chicken embryos. These findings are important because they suggest a potential new way to protect poultry from avian influenza infections. Who this helps: This helps poultry farmers and the farming industry by providing a natural method to protect their birds from disease.

Plain English
This study looked at how preschool teachers in North Carolina's Head Start programs view and experience professional learning communities (PLCs), which are groups where teachers collaborate and share teaching strategies. Out of 168 surveyed teachers, most had a positive view of PLCs but also noted challenges, such as lacking knowledge in specific topics like science and nutrition. The findings highlight the importance of supporting teachers in these areas to improve their instructional practices. Who this helps: This helps preschool teachers and ultimately benefits young children in their care.

Plain English
This paper summarizes discussions from a recent workshop where over 1,200 bioanalysis professionals gathered to focus on current issues related to measuring biomarkers and validating tests for new therapies and vaccines. The attendees made a series of recommendations aimed at improving testing quality and compliance with regulations to ensure better health outcomes. The importance of this work lies in its potential to enhance the reliability of new diagnostic tests and treatments, benefitting the overall healthcare system. Who this helps: Patients and healthcare providers benefit from these improved diagnostic tools and therapies.

Plain English
This study looked at how certain oral medications, called isocitrate dehydrogenase (IDH) inhibitors, can help adults with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). The researchers found that a combination of the drug ivosidenib and azacitidine improves survival rates for newly diagnosed AML patients compared to using azacitidine alone, but it is unclear how it compares to other treatments. Understanding the best treatment options is crucial because it can directly impact patient outcomes. Who this helps: This benefits patients with AML and MDS, particularly those with specific gene mutations.

Plain English
This study looked at how stressful experiences in childhood and adult work stress might affect the risk of developing gestational diabetes during pregnancy. Researchers found that pregnant women with work-related stress had more than double the risk of gestational diabetes (2.11 times higher) and that this risk was even greater for those who had experienced abuse in childhood (3.80 times higher). Understanding these connections is important because it highlights how past and present stress can impact the health of pregnant individuals and their babies. Who this helps: This helps pregnant individuals and their healthcare providers.

Plain English
This study looked at clinical trials for leukemia to see how many were conducted in low- and middle-income countries (LMICs) compared to high-income countries (HICs) from 2000 to 2020. Out of 3,345 trials, only 160 (about 4.8%) included LMICs. LMIC trials had better outcomes, with lower termination rates (12.5% vs. 27.5%) and were more likely to be randomized and involve larger participant groups, indicating that more trials in LMICs may lead to wider access to new treatments for leukemia. Who this helps: Patients in low- and middle-income countries gain access to important leukemia treatments.